BioSpace News Archive

The presentation will be webcast live from 1.20pm GMT.

Other Company Research Demonstrates the Value of Diagnostic Insights in Early Cardiovascular Disease Detection in Clinical and Workplace Settings

Varex Imaging Booth #1801 Direct Conversion Booth #1334 VMI Booth #1633 ASNT Fall 2019 Las Vegas, NV, USA Conference & Exhibit: 18-21 November

Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company focused on commercializing the Obalon Balloon System, the first and only FDA-approved swallowable, gas-filled intra-gastric balloon for weight loss, announces that Bill Plovanic, President and Chief Executive Officer, will present corporate overviews at the following investor conferences:

Tivic Health™ Systems Inc., a commercial phase bioelectronic company, today announced it has received ISO 13485:2016 certification for its quality management system (QMS), following review by the British Standards Institute (BSI)

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the Annual Investival Showcase to be held on November 19, 2019 at the Waldorf Hilton Hotel in London, England.

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the pricing of a public offering of (i) 10,450,000 Class A Units, each consisting of shares of its common stock and common warrants to purchase its common stock,

X-37, LLC, an artificial intelligence-enabled drug discovery company, announced today that it has closed a $14.5 million Series A financing.

Topline results expected before the end of Q1/2020

After an extensive review of startups with transformative technologies in the Life Sciences market, BioSpace today ranked SureClinical on its annual list of ‘Top 30 Life Science Startups To Watch In The U.S.’